Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference

May 14, 2024

https://www.globenewswire.com/news-release/2024/05/14/2881325/0/en/Belite-Bio-to-Participate-in-the-Benchmark-s-4th-Annual-Healthcare-House-Call-Investor-Conference.html

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ:BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference being held virtually on May 21 and 22, 2024. The Company will host a fireside chat at 3:00 pm ET on May 21, 2024.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.